StageZero Life Sciences Ltd News

Earnings Call Summary | STAGEZERO LIFE SCIENCES LTD(SZLSF.US) Q1 2024 Earnings Conference

The following is a summary of the StageZero Life Sciences Ltd. (SZLSF) Q1 2024 Earnings Call Transcript:Financial Performance:StageZero reported a decline in Q1 2024 revenue due to staff illnesses lea

moomoo AIMay 21 19:12 ET · Conference Call

StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update

TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for s

AccesswireMay 17 16:30 ET

Canadian Investment Regulatory Organization Trading Halt - SZLS

Stockhouse Apr 9 08:00 ET

StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order

TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-can

AccesswireApr 5 07:55 ET

StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results

TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-can

AccesswireApr 2 21:30 ET

StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update

TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic

AccesswireNov 15, 2023 07:45 ET

StageZero Life Sciences Partners With My One Medical Source and 1,000+ Medical Access Points in the USA

Aristotle and AVRT to be offered to My One Medical Source's Customer BaseTORONTO, ON / ACCESSWIRE / November 14, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Compa

AccesswireNov 14, 2023 11:20 ET

StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to impr

newsfileJun 20, 2023 07:29 ET

StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting

Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all

newsfileJun 7, 2023 19:28 ET

StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special

newsfileJun 5, 2023 17:17 ET

StageZero Life Sciences Ltd. GAAP EPS of -$0.02, Revenue of $0.8M

Seeking AlphaMay 16, 2023 16:37 ET

StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue Over Q4 2022 - and Operational Update

Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detect

newsfileMay 16, 2023 07:00 ET

StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023

Toronto, Ontario--(Newsfile Corp. - May 15, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results a

newsfileMay 15, 2023 10:51 ET

StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update

Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early dete

newsfileMar 31, 2023 21:25 ET

StageZero to Issue Q4 2022 Financial Results on Friday March 31

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 opera

newsfileMar 30, 2023 15:10 ET

StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 opera

newsfileMar 29, 2023 19:15 ET

Short Interest in StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Grows By 934.5%

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 30,000

kopsourceMar 27, 2023 20:33 ET

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Short Interest Down 46.9% in February

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 3,400 shares, a decline of 4

kopsourceMar 2, 2023 14:43 ET

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Short Interest Up 45.5% in January

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 6,400 shares, a

Financial News LiveFeb 14, 2023 00:01 ET

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Sees Large Growth in Short Interest

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 6,400 shares, a growth

kopsourceFeb 11, 2023 08:22 ET